1 – 10 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history
- Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice
- 2017
- Refractory subacute steatohepatitis after biliopancreatic diversion
- Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment
- Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients
- Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients
- Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival
- Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group
- Refractory subacute steatohepatitis after biliopancreatic diversion
- 2016
- Placental growth factor inhibition alleviates hepatopulmonary syndrome in mice